Author | John Horton, MBChB


Special Report: HER2 and Trastuzumab in Breast Cancer

August 03, 2011

The recognition and description of tumor growth control factors, together with the development of interventions that modulate their biologic activity, represent a major focus for current cancer research, which already has changed the practice of clinical oncology.